VivoSim Labs, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
VivoSim Labs, Inc. (VIVS) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $190.00 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-07-14
- VivoSim Labs, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2013-03-31 was $117.00K.
- VivoSim Labs, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2026 was $190.00K.
- VivoSim Labs, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was -$177.00K, a 133.71% decline from fiscal 2024.
- VivoSim Labs, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $525.00K, a 72.00% decline from fiscal 2023.
- VivoSim Labs, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $1.88M, a 3.40% decline from fiscal 2022.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|
| 2026-03-31 | $190.00K 10-K · filed 2026-07-14 | ||
| 2025-03-31 | -$177.00K 10-K · filed 2026-07-14 | ||
| 2024-03-31 | $525.00K 10-K · filed 2025-06-05 | ||
| 2023-03-31 | $1.88M 10-K · filed 2024-05-31 | ||
| 2022-03-31 | $1.94M 10-K · filed 2023-07-14 | -$1.94M 10-K · filed 2022-06-10 | |
| 2021-03-31 | -$1.55M 10-K · filed 2022-06-10 | ||
| 2020-03-31 | -$797.00K 10-K · filed 2021-06-15 | -$798.00K 10-K · filed 2020-05-28 | |
| 2019-03-31 | $39.00K 10-K · filed 2020-05-28 | ||
| 2018-03-31 | -$3.20M 10-K · filed 2019-06-03 | -$3.19M 10-K · filed 2018-05-31 | |
| 2017-03-31 | $1.68M 10-K · filed 2018-05-31 | ||
| 2016-03-31 | $2.11M 10-K · filed 2017-06-07 | ||
| 2015-03-31 | $2.00M 10-K · filed 2016-06-09 | ||
| 2014-03-31 | $1.28M 10-K · filed 2015-06-09 | ||
| 2013-03-31 | $117.00K 10-K · filed 2014-06-10 | ||
| 2012-12-31 | -$1.07M 10-KT · filed 2013-05-24 | $1.07M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |